Search the Newsreel

VALLEY WEALTH MANAGERS, INC.'s The Cigna Group(CI) Holding History

VALLEY WEALTH MANAGERS, INC. holds 1,227.00 shares of The Cigna Group (CI) valued at $338,270.00 as of June 30, 2026, representing 0.02% of their portfolio. The firm has made 14 purchases and 19 sales of CI since 2018Q2, with an estimated gain of $7.00 …

Cigna Group stock outperforms competitors on strong trading day

Cigna Group (CI) shares rose 1.64% to $282.56, outperforming the broader market on a day when the S&P 500 and Dow Jones Industrial Average both fell. This marks the third consecutive day of gains for Cigna Group's stock.

How Cigna’s Dividend Hike And Jefferies’ Downgrade At Cigna Group (CI) Has Changed Its Investment Story

Cigna Group recently declared a US$1.56 per share cash dividend with an ex-dividend date of September 8, 2026, while Jefferies downgraded its rating to 'hold' due to anticipated 2027 earnings headwinds. This situation highlights a tension between management's commitment to returning capital to shareholders …

Cigna Group declares Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 29

The Cigna Group has announced a Q3 2026 cash distribution of R$ 0.22 per unit (ISIN BRC1ICBDR000). Shares will trade with entitlement through September 3, 2026, with the payment scheduled for September 29, 2026. This news brief was generated by Public Technologies using AI …

Handelsbanken Fonder AB Buys 8,960 Shares of Cigna Group $CI

Handelsbanken Fonder AB increased its stake in Cigna Group (NYSE:CI) by 12.1% in the second quarter, acquiring an additional 8,960 shares, bringing its total to 82,825 shares valued at $22.83 million. Other institutional investors also adjusted their positions in Cigna. The article also details …

Cigna Group (CI) Reports Fresh Earnings, Is The 19% Undervaluation Story Still Compelling?

Cigna Group (CI) recently released its second-quarter and first-half earnings, with its stock currently trading at $277.41, showing an 8.9% decline over the last 30 days despite a 47.94% 5-year return. Analysts view the stock as 18.6% undervalued, with a fair value of $340.92, …

Cigna Group stock underperforms Tuesday when compared to competitors

Cigna Group (CI) stock fell by 1.63% on Tuesday, closing at $273.87, underperforming against a general market decline where the S&P 500 Index and Dow Jones Industrial Average also saw losses. This marked the second consecutive day of losses for Cigna Group's stock.

Are Wall Street Analysts Bullish on Cigna Group Stock?

Doctor stacking healthcare medical insurance icons by Dilok via Adobe Stock Headquartered in Bloomfield, Connecticut, The Cigna Group (CI) is a global health company focused on improving health and vitality. Through Cigna Healthcare and Evernorth Health Services, it provides healthcare and related services to …

Cigna Group (NYSE:CI) Receives Average Rating of "Moderate Buy" from Analysts

Cigna Group (NYSE:CI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $339.45. The company recently reported strong quarterly results, exceeding EPS expectations and seeing a 6.7% revenue increase. Cigna has also reaffirmed its fiscal 2026 EPS …

Cigna targets mid-market employers with Northern California appointment

Cigna Healthcare has appointed Luke Cirkovic as general manager for its Northern California market, focusing on employers with up to 2,999 employees. This move aligns with Cigna's strategic shift to prioritize its US employer business, following the sale of its Medicare Advantage business and …

Cigna Group $CI Holdings Lifted by NewEdge Advisors LLC

NewEdge Advisors LLC increased its holdings in Cigna Group (NYSE:CI) by 47.8% in the first quarter, bringing its stake to 34,277 shares valued at $9.14 million. Cigna reported strong quarterly earnings of $7.78 per share, exceeding analyst expectations, and declared a quarterly dividend of …

Cigna (CI) Stock Looks Undervalued As It Raises Full Year Outlook

Cigna (CI) stock appears undervalued despite a 46.9% return over five years and a recently raised full-year outlook. The company's P/E ratio of 11.6x is significantly lower than the Healthcare industry average of 24.9x and a peer group average of 32.1x, suggesting investors are …

Cigna Group | 4: Statement of changes in beneficial ownership of securities-Officer Cordani David

This article provides a link to a "Statement of changes in beneficial ownership of securities" (Form 4) filing for Cigna Group. The filing pertains to officer David Cordani. Without further content, the specific details of the changes in ownership are not available.

Cigna (CI) Stock Still Looks Cheap Following Raised 2026 Outlook

Cigna (CI) stock appears undervalued despite a 47.1% return over the past five years and recent strong earnings, including a raised 2026 outlook. The company trades at a P/E of 11.6x, significantly below the healthcare industry average of 25.3x, suggesting it remains inexpensive. While …

Cigna Group (CI) Reports Q2 Earnings And Buybacks, Is It Trading At A Discount?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back …

Cigna Group (NYSE: CI) EVP sells 19,436 shares after option exercise

Cigna Group's EVP, Nicole S. Jones, exercised 15,346 employee stock options and subsequently sold 19,436 common shares on August 4-5, 2026. These transactions, valued at approximately $5.37 million, were conducted under a pre-adopted Rule 10b5-1 trading plan. After the sales, Jones retains 28,557 direct …

Pacer Advisors Inc. Sells 17,053 Shares of Cigna Group $CI

Pacer Advisors Inc. significantly reduced its stake in Cigna Group (NYSE:CI) during the first quarter, selling 17,053 shares, which represents a 56.4% decrease. Despite this, institutional investors collectively own a substantial 86.99% of Cigna's stock, and Wall Street analysts generally maintain a "Moderate Buy" …

Insider Selling: Cigna Group (NYSE:CI) Insider Sells $5,369,583.72 in Stock

Cigna Group insider Nicole Jones sold 19,436 shares of the company's stock for approximately $5.37 million, reducing her direct ownership by 41.63%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider selling, Cigna's shares rose, and the company reported …

Why Cigna Group (CI) Is Down 9.0% After Strong Q2 Results Meet PBM and Regulatory Jitters

Cigna Group (CI) reported strong Q2 2026 results with increased revenue and net income, alongside continued share repurchases. Despite this, the stock dropped 9.0% due to heightened regulatory scrutiny over its pharmacy benefit management (PBM) operations and ongoing business portfolio review. Analysts have expressed …

Cigna Wins Dismissal Of Pa. In-Network Pharmacy Suit

A Pennsylvania federal judge dismissed a lawsuit against Cigna, Evernorth, and Express Scripts. The suit was brought by pharmacy customers who claimed injury because their community pharmacy was designated as out-of-network. The article, authored by Kellie Mejdrich, was published on August 6, 2026, at …

Cigna Healthcare Names Luke Cirkovic General Manager for Northern California Market

Cigna Healthcare has appointed Luke Cirkovic as the new general manager for its Northern California market, effective August 10, 2026. Cirkovic will focus on driving customer and earnings growth for employers with up to 2,999 employees and strengthening Cigna Healthcare's presence in the community. …

The CEO Who Built Modern Cigna

This article details David Cordani's 17-year tenure as Cigna CEO, during which he transformed the company into a $275 billion healthcare giant. The author highlights Cordani's strategic maneuvers, including the acquisition of Express Scripts, and discusses the mounting legal scrutiny and controversies, such as …

Cigna Group (CI) Faces A Valuation Test As Earnings Strength Meets PBM Concerns

Cigna Group (CI) is facing a valuation test as its recent earnings strength and shareholder returns are balanced against PBM (Pharmacy Benefit Manager) concerns and a recent downgrade. Despite these headwinds, the company is seen as undervalued by Simply Wall St's narrative, with a …

Jefferies downgrades Cigna to Hold on mounting 2027 earnings headwinds

Investing.com -- Jefferies downgraded Cigna to Hold from Buy, arguing that a growing list of earnings headwinds and limited catalysts outweigh the stock's discounted valuation, while cutting its price target to $307 from $336. The brokerage said consensus earnings expectations for 2027 remain too …

CI Downgraded by Jefferies -- Price Target Lowered to $307

Jefferies has downgraded Cigna Group (CI) to a "Hold" rating, lowering its price target to $307 from $336 due to a cautious outlook on the company's performance. Despite a seemingly undervalued P/E ratio and strong profitability and growth ranks, significant insider selling of $59.4 …

Cigna Stock (CI) Opinions on Recent Analyst Downgrades Following Q2 Earnings

Cigna Group (CI) Stock Analysis: Exploring A Potential 23% Upside In The Healthcare Sector

Cigna Group (CI) is presented as an attractive investment in the healthcare sector, offering potential long-term growth and stability. Analysts have given the stock 20 buy ratings and 4 hold ratings, with an average target price suggesting a 23.05% upside. The company demonstrates robust …

Cigna Group stock rises Monday, still underperforms market

Cigna Group (CI) stock rose 1.08% on Monday, closing at $282.06, despite the broader market also seeing gains. The stock's performance still lagged behind the S&P 500 Index and the Dow Jones Industrial Average, which rose 1.48% and 1.32% respectively. This increase ended a …

Raymond James cuts Cigna to Outperform on lack of near-term catalysts

Raymond James downgraded Cigna Group (CI) from Strong Buy to Outperform and lowered its price target to $320 from $350, citing a lack of near-term catalysts despite an attractive valuation. The firm noted slower growth in Cigna's mature market and ongoing headwinds in its …

Goldman Sachs Adjusts Price Target on Cigna Group to $352 From $340, Maintain Buy Rating

Goldman Sachs has increased its price target for Cigna Group (CI) to $352 from $340, while reaffirming a Buy rating on the stock. This adjustment reflects an updated outlook from the investment bank regarding the managed healthcare company. The article also notes recent analyst …

Raymond James Adjusts Price Target on Cigna Group to $320 From $350, Maintain Outperform Rating

Raymond James has adjusted its price target for Cigna Group (CI) to $320, down from $350, while maintaining an Outperform rating on the stock. Cigna Group currently holds an average analyst rating of overweight and a mean price target of $342.43. The full details …

Cigna: Specialty Care Profit Jumps 22% As Pharmacy Benefit Earnings Fall 27%

Cigna's second-quarter 2026 earnings showed a significant divergence between its Evernorth Health Services businesses. Specialty and Care Services saw its profit jump 22% due to strong specialty-drug growth and operational efficiencies, while Pharmacy Benefit Services experienced a 27% decline in earnings despite increased revenue, …

Health insurer Cigna boosts full-year earnings guidance after beating Q2 expectations

Cigna has raised its 2026 profit forecast to at least $30.45 per share, an increase of $0.10 from its previous outlook, following strong second-quarter results that surpassed analyst expectations. The improved performance was primarily driven by its Evernorth Health Services division, particularly the Specialty …